Combination of acupuncture and traditional Chinese medicine to improve the sciatica of lumbar disc herniation: a randomized controlled trial

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: Testing group:Shenxie Zhitong capsule + Acupuncture treatment (Yaojiaji, Yaotu, Huantiao and Weizhong);Control group:Celecoxib Capsules; CONDITION: ICD10: M51.1 sciatica of lumbar disc herniation PRIMARY OUTCOME: visual analogue scale for intensity of sciatica(0‐10: 0 = no pain, 10 worst pain); SECONDARY OUTCOME: VAS for leg pain intensity (0‐10: 0 = no pain, 10 worst pain);VAS for central back pain intensity (0‐10: 0 = no pain, 10 worst pain);VAS for leg pain frequency (0‐10: 0= never, 10 constant);VAS for central back pain frequency(0‐10: 0 = no pain, 10 worst pain);Oswestry Disability Inde X(function specific outcome measure);SF‐36 (Generic health outcome measure);Return to Work Status;Satisfaction; INCLUSION CRITERIA: 1. 18 – 75 years old 2. Unilateral, single L5 or S1 radiculopathy (leg pain following dermatomal distribution) a. Leg dominant pain b. Positive straight leg raise <70 degrees 3. MRI with corresponding L4‐5 or L5‐S1 posterolateral disc herniation 4. VAS score for leg pain intensity 4‐7 (0‐10:0 = no pain, 10 worst pain) 5. Radicular symptom duration greater than 3 months <12 months. 6. Participate voluntarily in this trial and sign the "Informed Consent Form".
Epistemonikos ID: 16ec7452a6faa7214c6c908183646fb3b841ae82
First added on: Feb 20, 2024